DVA Trading Analysis - 10/07/2026 11:29 AM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for DaVita (DVA) that may frame the current data environment:

• DaVita continues to navigate kidney-care reimbursement shifts under CMS policies, with potential margin pressure from proposed dialysis payment rule changes.
• Labor cost inflation and staffing shortages across U.S. dialysis centers remain a recurring operational concern for DVA.
• Recent sector rotation into value-healthcare names has highlighted DVA's relatively low trailing P/E versus broader market.
• No major earnings catalyst confirmed in provided data; next fiscal year-end per fundamentals is 2025-12-01, suggesting prior-year reporting already occurred.
• News context contrasts with embedded technical weakness: while fundamental valuation looks cheap, price remains below major SMAs and shows bearish momentum.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for DVA:

• Trailing P/E is 14.50 with trailing EPS of 12.46, implying a comparatively modest valuation versus high-growth healthcare peers.
• Market cap is 11,406,164,000.00 with shares outstanding of 63,800,000.00 and institutional ownership at 28.91%.
• Dividend yield is 0.00 with no dividend rate or ex-dividend date reported.
• Beta is 1.23, indicating moderately higher volatility than the broad market.
• 52-week high is 247.49 and 52-week low is 101.00; current price near 180.80 sits in the lower-middle of that annual range.
• PEG ratio, forward P/E, forward EPS, profit margins, ROE, debt/equity, and free cash flow are all null — not available in data.
• Average volume is 702,000.00; historical volatility is 31.32%.
• Analyst consensus and target mean price are null; no recommendation key provided.
• Fundamentals show a low multiple and stable EPS, but the technical picture is weak (price below 50-day SMA of 187.25), creating a divergence between cheap valuation and bearish price trend.

Current Market Position

From the embedded daily and minute data:

• Current price per indicators is 180.80 as of 2026-10-06; minute bars show 2026-10-07 11:00 close at 179.43.
• Daily close on 2026-10-06 was 180.80 after trading range of 178.88 to 181.82 with volume 193,759 (below 20-day avg of 400,674).
• Minute bars 2026-10-06 opened 179.88, peaked 181.27 by 09:40, then drifted; 2026-10-07 10:55 shows high volume 34,103 and drop to 178.97 low, closing 179.43 at 11:00.
• Intraday momentum is softening: last 5 minute bars show rejection from ~182.04 and push to 178.39 low.

Technical Analysis

• Price (180.80) is above SMA 5 (178.17) but below SMA 20 (181.65) and SMA 50 (187.25) — bearish alignment with no golden cross.
• RSI at 32.39 shows weak momentum, approaching oversold but not yet extreme (<30).
• MACD (-3.06) below signal (-2.45) with negative histogram (-0.61) confirms bearish momentum.
• Bollinger Bands: price inside lower-middle; middle band 181.65 acts as near-term resistance, lower band 171.65 as support.
• 30-day range high 195.75, low 173.37; current price sits roughly 38% up from low to high range.

True Sentiment Analysis (Delta 40-60 Options)

From the TRUE SENTIMENT OPTIONS data:

Call Volume: $0.00 (0.00%) Put Volume: $0.00 (0.00%) Total: $0.00

• Sentiment is labeled "Balanced" with 0 directional contracts filtered from 804 total options.
• No call or put dollar volume in delta 40-60 band — no pure directional conviction signal.
• Options flow shows neutral bias, contrasting with technically bearish indicators (RSI 32.39, MACD negative).
• Divergence: price weakness not confirmed by directional options bets; traders may be awaiting catalyst.

Key Price Levels (Observational Only)